113 related articles for article (PubMed ID: 2870166)
1. Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activity.
Grinpukel S; Sewell R; Yeomans N; Mihaly G; Smallwood R
J Pharm Pharmacol; 1986 Feb; 38(2):158-60. PubMed ID: 2870166
[TBL] [Abstract][Full Text] [Related]
2. Effects of rabeprazole, a gastric proton pump inhibitor, on biliary and hepatic lysosomal enzymes in rats.
Fujisaki H; Oketani K; Nagakawa J; Takenaka O; Yamanishi Y
Jpn J Pharmacol; 1998 Mar; 76(3):279-88. PubMed ID: 9593221
[TBL] [Abstract][Full Text] [Related]
3. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
4. Effect of omeprazole and polyethylene glycol-400 on antipyrine elimination by the isolated perfused rat liver.
Webster LK; Jones DB; Mihaly GW; Smallwood RA
J Pharm Pharmacol; 1984 Jul; 36(7):470-2. PubMed ID: 6146695
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic perturbation of rat liver lysosomes: effects on release of lysosomal enzymes and of lipids into bile.
Sewell RB; Grinpukel SA; Zinsmeister AR; LaRusso NF
Gastroenterology; 1988 Oct; 95(4):1088-98. PubMed ID: 3137115
[TBL] [Abstract][Full Text] [Related]
6. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
8. The effect of actinomycin D on the rhythm of activity of some lysosomal hydrolases in the rat liver.
Lityńska A; Twardowski J; Proniewicz M
Folia Biol (Krakow); 1983; 31(1):13-7. PubMed ID: 6411503
[No Abstract] [Full Text] [Related]
9. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Im WB; Blakeman DP; Davis JP
Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Hirano T; Manabe T; Calne R; Tobe T
Scand J Gastroenterol; 1992; 27(3):227-32. PubMed ID: 1502486
[TBL] [Abstract][Full Text] [Related]
11. Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins.
Sewell RB; Barham SS; LaRusso NF
Gastroenterology; 1983 Nov; 85(5):1146-53. PubMed ID: 6413291
[TBL] [Abstract][Full Text] [Related]
12. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification.
Howden CW; Reid JL
Eur J Clin Pharmacol; 1984; 26(5):639-40. PubMed ID: 6088253
[TBL] [Abstract][Full Text] [Related]
15. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Howden CW; Forrest JA; Reid JL
Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
[TBL] [Abstract][Full Text] [Related]
16. Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration.
Burdan F; Siezieniewska Z; Maciejewski R; Madej B; Radzikowska E; Wojtowicz Z
Exp Toxicol Pathol; 2002 Feb; 53(6):453-9. PubMed ID: 11926287
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal enzyme in Mastomys natalensis during Dipetalonema viteae infection.
Srivastava AK; Singh DP; Chatterjee RK; Ghatak S
Tropenmed Parasitol; 1983 Sep; 34(3):174-6. PubMed ID: 6415875
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of action of omeprazole.
Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH
Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525
[TBL] [Abstract][Full Text] [Related]
19. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
[TBL] [Abstract][Full Text] [Related]
20. Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload.
LeSage GD; Kost LJ; Barham SS; LaRusso NF
J Clin Invest; 1986 Jan; 77(1):90-7. PubMed ID: 3944262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
